Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.000001 per share
Symbol
XTNT on NYSE
Shares outstanding
139,295,316
Price per share
$0.78
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
80,064,654
Total reported value
$51,958,021
% of total 13F portfolios
0%
Share change
+101,444
Value change
+$59,665
Number of holders
29
Price from insider filings
$0.78
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 49% 0% $32,829,120 68,394,000 0% Nantahala Capital Management, LLC 01 Aug 2025
LYTTON LAURENCE W 6.8% $4,447,818 9,463,442 Laurence W. Lytton 15 Apr 2025

As of 30 Sep 2025, 29 institutional investors reported holding 80,064,654 shares of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT). This represents 57% of the company’s total 139,295,316 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 49% 68,394,000 0% 2.7% $44,380,866
AWM Investment Company, Inc. 4.7% 6,594,121 -0.04% 0.4% $4,278,925
VANGUARD GROUP INC 1.7% 2,355,671 +4.6% 0% $1,528,830
RENAISSANCE TECHNOLOGIES LLC 0.51% 713,915 +9.7% 0% $463,259
GEODE CAPITAL MANAGEMENT, LLC 0.35% 491,949 -11% 0% $319,313
Crescent Grove Advisors, LLC 0.3% 412,024 0% 0.03% $267,362
MILLENNIUM MANAGEMENT LLC 0.17% 242,924 -7.5% 0% $157,633
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.12% 164,100 0% 0% $106,484
Private Advisor Group, LLC 0.09% 123,000 0% 0% $79,815
BlackRock, Inc. 0.09% 120,326 0% 0% $78,080
Mink Brook Asset Management LLC 0.08% 109,466 0% 0.05% $71,032
CITADEL ADVISORS LLC 0.06% 80,077 +20% 0% $51,962
NORTHERN TRUST CORP 0.04% 58,666 0% 0% $38,068
HRT FINANCIAL LP 0.03% 40,803 0% $26,000
Virtu Financial LLC 0.02% 31,664 +87% 0% $21,000
STATE STREET CORP 0.02% 31,266 0% 0% $20,289
PRUDENTIAL FINANCIAL INC 0.02% 23,400 +43% 0% $15,184
Equitable Holdings, Inc. 0.02% 21,450 0% 0% $13,919
GOLDMAN SACHS GROUP INC 0.02% 21,034 0% $13,649
Petros Family Wealth, LLC 0.01% 20,000 0% 0.01% $12,978
Larson Financial Group LLC 0.01% 10,000 0% $6,489
Tower Research Capital LLC (TRC) 0% 3,570 -38% 0% $2,317
UBS Group AG 0% 395 +39400% 0% $257
BANK OF AMERICA CORP /DE/ 0% 393 -28% 0% $254
VALLEY WEALTH MANAGERS, INC. 0% 298 0% 0% $193

Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,000 $1,568 -$11,410 $0.78 1
2025 Q3 80,064,654 $51,958,021 +$59,665 $0.65 29
2025 Q2 79,963,210 $59,092,411 +$9,527,080 $0.74 29
2025 Q1 96,332,001 $45,274,819 -$166,230 $0.47 26
2024 Q4 96,692,530 $42,834,946 -$1,064,036 $0.44 28
2024 Q3 98,215,048 $66,126,833 +$5,325,349 $0.68 27
2024 Q2 90,066,890 $56,742,224 -$435,634 $0.63 26
2024 Q1 90,374,373 $105,738,076 +$203,993 $1.17 32
2023 Q4 90,202,353 $101,928,562 -$82,273 $1.13 31
2023 Q3 90,276,097 $99,304,130 +$9,366,345 $1.10 28
2023 Q2 81,765,290 $76,033,381 -$53,519 $0.93 19
2023 Q1 81,854,114 $52,181,371 -$34,623 $0.64 21
2022 Q4 81,903,315 $54,055,427 +$153,020 $0.66 18
2022 Q3 897 $1,000 -$21,998 $1.11 1
2022 Q2 80,613,065 $41,878,151 +$42,651 $0.52 12
2022 Q1 80,513,993 $54,749,198 -$68,430 $0.68 13
2021 Q4 80,638,747 $45,158,000 +$86,026 $0.56 15
2021 Q3 80,508,571 $89,363,000 -$2,471,552 $1.11 12
2021 Q2 82,710,575 $134,818,000 +$13,336,777 $1.63 14
2021 Q1 74,502,096 $175,824,000 +$1,770,235 $2.36 14
2020 Q4 73,758,594 $88,222,000 +$76,213,201 $1.19 9
2020 Q3 10,131,401 $8,345,000 -$186,740 $0.82 12
2020 Q2 10,345,548 $9,310,000 -$901,419 $0.90 10
2020 Q1 11,668,872 $7,817,000 +$8,454 $0.67 9
2019 Q4 11,655,600 $18,649,000 -$25,979 $1.60 8
2019 Q3 522 $1,000 +$1,000 $1.92 1
2019 Q2 11,679,733 $35,039,000 +$50,901 $3.00 10
2019 Q1 11,662,801 $35,571,000 -$210,499 $3.05 9
2018 Q4 11,733,772 $18,890,000 +$70,170 $1.61 10
2018 Q3 11,689,971 $45,008,000 +$2,792,757 $3.85 9
2018 Q2 10,963,522 $60,849,000 +$2,123,826 $5.55 11
2018 Q1 10,569,346 $83,106,926 +$83,107,298 $7.89 10